Expanding Global Cancer Research
We’re happy to announce the launch of the Rosalind Study in Dubai in collaboration with Mediclinic Middle East City Hospital and Dr. Shaheenah Dawood!
This important milestone expands our global Cancer r
esearch network and strengthens our mission to unlock the biology of exceptional Cancer survivors. By studying why some patients beat the odds, the Rosalind Study aims to transform their resilience into scientific insights and accelerate the development of innovative Cancer therapies.
Advancing Cancer Survival Science
Mediclinic City Hospital’s Comprehensive Cancer Centre is one of the UAE’s leading oncology institutions, equipped with cutting-edge radiotherapy technology such as Varian TrueBeam, advanced imaging and a multidisciplinary team delivering world-class Cancer care and treatment.
“We’re honoured for Mediclinic City Hospital to join this global effort to understand why certain patients overcome Cancer against all expectations,” said Dr. Shaheenah Dawood. “These stories have the power to inspire the future of treatment and survival.”
With 100+ centres in over 50 countries, the Rosalind Study continues to grow as a global Cancer research initiative, uniting researchers, clinicians and Cancer survivors under one shared vision: turning survival into science, and science into new hope in the fight against Cancer.
Updated: Dec 24, 2025
